Search Results - "Simard, J F"

Refine Results
  1. 1

    Juvenile idiopathic arthritis and risk of cancer: A nationwide cohort study by Simard, J. F., Neovius, M., Hagelberg, S., Askling, J.

    Published in Arthritis & rheumatology (Hoboken, N.J.) (01-12-2010)
    “…Objective Reports of therapy‐related adverse events suggest an elevated rate of malignancy in patients with juvenile idiopathic arthritis (JIA) treated with…”
    Get full text
    Journal Article
  2. 2

    Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab by Neovius, M, Arkema, E V, Olsson, H, Eriksson, J K, Kristensen, L E, Simard, J F, Askling, J

    Published in Annals of the rheumatic diseases (01-02-2015)
    “…To compare drug survival on adalimumab, etanercept and infliximab in patients with rheumatoid arthritis (RA). Patients with RA (n=9139; 76% women; mean age 56…”
    Get more information
    Journal Article
  3. 3

    Sick leave and disability pension before and after initiation of antirheumatic therapies in clinical practice by Neovius, M, Simard, J F, Klareskog, L, Askling, J

    Published in Annals of the rheumatic diseases (01-08-2011)
    “…To investigate sick leave and disability pension in rheumatoid arthritis (RA) in relation to the initiation of biological and non-biological antirheumatic…”
    Get more information
    Journal Article
  4. 4

    Sick leave and disability pension following delivery in women with systemic lupus erythematosus by Grannas, D, Simard, J F, Svenungsson, E, Arkema, E V, Gernaat, Sam

    “…To investigate sickness benefits following delivery in mothers with systemic lupus erythematosus (SLE) and mothers without SLE. SLE and non-SLE mothers,…”
    Get full text
    Journal Article
  5. 5

    Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis by Finckh, A, Simard, J F, Gabay, C, Guerne, P-A

    Published in Annals of the rheumatic diseases (01-06-2006)
    “…Background: Acquired drug resistance or gradual drug failure has been described with most disease modifying antirheumatic drugs (DMARDs) and is also starting…”
    Get full text
    Journal Article
  6. 6

    Preterm birth phenotypes in women with autoimmune rheumatic diseases: a population‐based cohort study by Kolstad, KD, Mayo, JA, Chung, L, Chaichian, Y, Kelly, VM, Druzin, M, Stevenson, DK, Shaw, GM, Simard, JF

    “…Objective To investigate preterm birth (PTB) phenotypes in women with different autoimmune rheumatic diseases in a large population‐based cohort. Design…”
    Get full text
    Journal Article
  7. 7

    Time Trends in Risk and Risk Determinants of Non‐Hodgkin Lymphoma in Solid Organ Transplant Recipients by Fernberg, P., Edgren, G., Adami, J., Ingvar, Å., Bellocco, R., Tufveson, G., Höglund, P., Kinch, A., Simard, J. F., Baecklund, E., Lindelöf, B., Pawitan, Y., Smedby, K. E.

    Published in American journal of transplantation (01-11-2011)
    “…Organ transplantation increases risk of non‐Hodgkin lymphoma (NHL), but long‐term risk and time trends have seldom been evaluated. Immunosuppressive drug load…”
    Get full text
    Journal Article
  8. 8

    Endometriosis and systemic lupus erythematosus: a population-based case–control study by Harris, H R, Simard, J F, Arkema, E V

    Published in Lupus (01-08-2016)
    “…Objective To investigate the association between endometriosis and systemic lupus erythematosus (SLE) in prospectively collected population-based data. Methods…”
    Get full text
    Journal Article
  9. 9

    What is the impact of chronic systemic inflammation such as rheumatoid arthritis on mortality following cancer? by Simard, J F, Ekberg, S, Johansson, A L V, Askling, J

    Published in Annals of the rheumatic diseases (01-05-2016)
    “…Emerging evidence links inflammation and immune competence to cancer progression and outcome. Few studies addressing cancer survival in the context of…”
    Get more information
    Journal Article
  10. 10

    Pediatric Organ Transplantation and Risk of Premalignant and Malignant Tumors in Sweden by Simard, J. F., Baecklund, E., Kinch, A., Brattström, C., Ingvar, Å., Molin, D., Adami, J., Fernberg, P., Wilczek, H., Ekbom, A., Smedby, K. E.

    Published in American journal of transplantation (01-01-2011)
    “…Increased cancer risks are well documented in adult organ transplant recipients. However, the spectrum of malignancies and risk in the pediatric organ…”
    Get full text
    Journal Article
  11. 11

    Risk of ischaemic heart disease and cardiomyopathy in patients with haemochromatosis and in their first-degree relatives: a nationwide, population-based study by Elmberg, M., Hultcrantz, R., Simard, J. F., Stål, P., Pehrsson, K., Askling, J.

    Published in Journal of internal medicine (01-07-2012)
    “…  Elmberg M, Hultcrantz R, Simard JF, Stål P, Pehrsson K, Askling J (Karolinska University Hospital and Karolinska Institutet, Solna; Karolinska Institutet,…”
    Get full text
    Journal Article
  12. 12

    Perinatal risk factors for future SLE: a population-based nested case-control study by Arkema, E V, Simard, J F

    Published in Lupus (01-07-2015)
    “…Objective To investigate the association between perinatal characteristics and the offspring’s risk of lupus using population-based registers in Sweden…”
    Get full text
    Journal Article
  13. 13

    Is birthweight associated with risk of rheumatoid arthritis? Data from a large cohort study by Mandl, L A, Costenbader, K H, Simard, J F, Karlson, E W

    Published in Annals of the rheumatic diseases (01-04-2009)
    “…The "fetal origins of adult disease" hypothesis suggests the uterine environment can influence the susceptibility of a fetus to future disease. We examine…”
    Get more information
    Journal Article
  14. 14

    PO.7.162 Epidemiology of systemic lupus erythematosus in central Sweden: a population-based cohort study from the östergötland county over 14 years by Arkema, EV, Saleh, M, Simard, JF, Sjöwall, C

    Published in Lupus science & medicine (01-10-2022)
    “…PurposeWe examined variations in incidence and prevalence of systemic lupus erythematosus (SLE) within a geographically defined area of central Sweden over a…”
    Get full text
    Journal Article
  15. 15

    Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register by Neovius, M, Simard, Jf, Sundström, A, Jacobsson, L, Geborek, P, Saxne, T, Feltelius, N, Klareskog, L, Askling, J

    Published in Annals of the rheumatic diseases (01-03-2011)
    “…To determine coverage and generalisability of data in the Swedish Biologics Register ARTIS. Patients with adult onset rheumatoid arthritis (RA) were identified…”
    Get more information
    Journal Article
  16. 16

    What can epidemiology tell us about systemic lupus erythematosus? by Simard, J F, Costenbader, K H

    “…Systemic lupus erythematosus (SLE) is an often-severe autoimmune rheumatic disease most commonly diagnosed in women in their childbearing years. It is thought…”
    Get more information
    Journal Article
  17. 17

    Small-area variations in sales of TNF inhibitors in Sweden between 2000 and 2009 by Neovius, M, Sundström, A, Simard, JF, Wettermark, B, Cars, T, Feltelius, N, Askling, J, Klareskog, L

    Published in Scandinavian journal of rheumatology (01-01-2011)
    “…Objective: To measure small-area variations in sales per capita of tumour necrosis factor (TNF) inhibitors. Methods: For 2000-2009, sales data on etanercept,…”
    Get full text
    Journal Article
  18. 18

    Exposure to maternal smoking and incident SLE in a prospective cohort study by Simard, JF, Costenbader, KH, Liang, MH, Karlson, EW, Mittleman, MA

    Published in Lupus (01-04-2009)
    “…Current cigarette smoking is a risk factor for SLE, and recent work has demonstrated that early-life smoke exposure was related to the risk of related…”
    Get full text
    Journal Article
  19. 19

    Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden by Raaschou, Pauline, Simard, Julia F, Holmqvist, Marie, Askling, Johan

    Published in BMJ (Online) (08-04-2013)
    “…Objectives To investigate the potential association between tumour necrosis factor (TNF) inhibitor treatment and malignant melanomas in rheumatoid arthritis,…”
    Get full text
    Journal Article
  20. 20

    Does SLE widen or narrow race/ethnic disparities in the risk of five co-morbid conditions? Evidence from a community-based outpatient care system by Falasinnu, T, Chaichian, Y, Li, J, Chung, S, Waitzfelder, B E, Fortmann, S P, Palaniappan, L, Simard, J F

    Published in Lupus (01-12-2019)
    “…Objective The heterogeneous spectrum of systemic lupus erythematosus (SLE) often presents with secondary complications such as cardiovascular disease (CVD),…”
    Get full text
    Journal Article